Invivyd, Inc. (IVVD)
Nasdaq: IVVD · Biological Products, (No Diagnostic Substances) · New Haven, CT · filing with the SEC since 2020
Who owns Invivyd, Inc.
As filed with the SECHolders of 5% or more
7
Janus Henderson Group PLC holds 12.1% of Common Stock, as its SCHEDULE 13G/A filed Nov 14, 2025 says.
Directors and officers
13
report now, of 34 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Janus Henderson Group PLC
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock · 11.6% in Sep 8, 2025
Bvf Partners L P/il
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value per share · 9% in Feb 17, 2026
Adimab, LLC
SCHEDULE 13D/A · filed Dec 29, 2025 · Common Stock, $0.0001 par value per share · 8.8% in Nov 19, 2025
RA Capital Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share · 9.9% in Feb 17, 2026
Maverick Capital, Ltd.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, $0.0001 par value per share · 8.5% in Aug 14, 2025
Perceptive Advisors LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value per share · 7.9% in Nov 25, 2025
Blackrock, Inc.
SCHEDULE 13G · filed Jul 28, 2026 · Common Stock
Mithril II LP
SCHEDULE 13D/A · filed Nov 12, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
Fmr LLC
SCHEDULE 13G/A · filed Feb 12, 2025 · COMMON STOCK · reported falling below 5%
Marc Elia
SCHEDULE 13D/A · filed Aug 26, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
Terrance McGuire
SCHEDULE 13D/A · filed Nov 7, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
Soleus Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 12, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.1% in Oct 14, 2025
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6% in Feb 17, 2026
Deep Track Capital, LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%, from 8.1% in May 15, 2025
What IVVD reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 5, 2026.
Insider tradesForm 4
20sales
1purchases
20sales on a scheduled plan
5people selling
$500,000sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 54 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Andersen Jill | Chief Legal Officer, Secretary | 4 | $200,000 | 4 | 0 | $0 |
| Duke William E. | Chief Financial Officer | 4 | $100,000 | 4 | 0 | $0 |
| Allen Robert D. III | Chief Scientific Officer | 4 | $100,000 | 4 | 0 | $0 |
| Green Julie | Chief Human Resources Officer | 4 | $100,000 | 4 | 0 | $0 |
| Lee Timothy Edward | Chief Commercial Officer | 4 | $100,000 | 4 | 0 | $0 |
| Mclaughlin Kevin F | director | 0 | $0 | 0 | 1 | $100,000 |